Member Exclusive News

The week in industry: Overall decline in 2019 Q3 growth for top five pharmaceutical companies

This week: Advancing hearing therapeutics with a new partnership, forwarding cannabinoid-based preclinical research through collaboration and first anti-PD-1 for non-muscle-invasive bladder cancer gains FDA approval.

Go to the profile of RxNet
Jan 09, 2020
0
0

Please sign in or register for FREE

No comments yet.